A Structural Nanomedicine Platform for Efficient Extrahepatic Delivery of Nucleic Acid Therapeutics

• Applying the discovery of spherical nucleic acids by Chad Mirkin’s laboratory at Northwestern University to multiple treatment modalities, including immuno-oncology, RNA therapeutics, non-viral gene therapy, gene editing, and in vivo CAR-T
• Improving stability and cellular uptake via precision-engineered architecture
• Avoiding hepatic accumulation and targeting disease-specific tissues

Speakers:

Venkat Krishnamurthy

Chief Scientific Officer

Flashpoint Therapeutics